Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
2022 · The Lancet. Gastroenterology & hepatology · 157 citations
https://doi.org/10.1016/s2468-1253(22)00093-0
B
Binita M. Kamath
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
267
Papers
8.8K
Citations
55
h-index
135
i10-index
Binita M. Kamath is an academic researcher from Children's Hospital of Philadelphia. The author has contributed to research in topics: Pediatric Hepatobiliary Diseases and Treatments & Gallbladder and Bile Duct Disorders & Liver Diseases and Immunity. The author has an h-index of 55, co-authored 227 publications.
ORCID: 0000-0002-9982-5023Papers by this author
worksAlagille syndrome: clinical perspectives
2016 · The Application of Clinical Genetics · 139 citations
https://doi.org/10.2147/tacg.s86420
Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis
2016 · Hepatology · 86 citations
https://doi.org/10.1002/hep.29019
Supernumerary digital flexion creases: An additional clinical manifestation of Alagille syndrome
2002 · American Journal of Medical Genetics · 60 citations
https://doi.org/10.1002/ajmg.10628
EASL Clinical Practice Guidelines on genetic cholestatic liver diseases
2024 · Journal of Hepatology · 56 citations
https://doi.org/10.1016/j.jhep.2024.04.006
Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?
2023 · Journal of Hepatology · 50 citations
https://doi.org/10.1016/j.jhep.2023.02.030
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat